Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Gastroprotective and Antioxidant Properties of Linalyl Acetate in Ethanol-Induced Gastric Ulcer in Rats
Zahra Navvabi1, Hossein Anousheh1, Bahman Jalali Kondori2
1Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Background:
Gastric ulcer is a major public health problem with a high morbidity of approximately 5-10%. Natural compounds with potent antioxidant, anti-inflammatory, and antiapoptotic activities may offer good gastrointestinal protection. Linalyl acetate (Lin) traditionally used for the treatment of various diseases for decades. In this study, we assessed the gastroprotective action of Lin against ethanol-induced gastric ulcers in rats and explored its potential mechanisms.
Materials And Methods:
Male Wistar rats separated into 5 groups: I (sham), II (gastric ulcer), and III-V (Lin + gastric ulcer). Group II orally treated with ethanol 90% (1 ml/200 g). Groups III-V pretreated with three different doses (10, 20, and 40 mg/kg) of Lin. After an hour, the groups III-V fed with ethanol 90%. After another hour, all rats sacrificed. Then, gastric tissues examined through macroscopic evaluation (gastric ulcer index and protection index) and total oxidant status (TOS) and total antioxidant capacity (TAC). Furthermore, pH value and gastric juice volume assessed in pylorus ligation model.
Results:
Pretreatment with Lin at doses of 10, 20, and 40 mg/kg (orally) significantly decreased ethanol-induced gastric mucosal injuries [number of ulcers, severity of gastric ulcers, and ulcer Index] in rats. Pretreatment with Lin also decreased the gastric ulcer by decreasing the gastric juice volume and gastric TOS.
Conclusions:
These results suggest that the administration of Lin promotes protection against ethanol-induced gastric ulcers in rats likely by the decreasing of the gastric juice volume and gastric TOS.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
07:42Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...